XML 49 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Debt (Details)
$ in Millions
1 Months Ended 3 Months Ended
Jan. 24, 2019
USD ($)
Jun. 30, 2018
USD ($)
item
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
Debt        
Debt issuance costs       $ 0.7
Arena Pharmaceuticals, Inc.        
Debt        
Upfront payment $ 800.0      
Credit Agreement        
Debt        
Debt, maturity term   5 years    
Period of extension in maturity   1 year    
Number of extensions | item   2    
Interest expense     $ 10.3  
Debt issuance costs   $ 13.2    
Debt issuance costs capitalized   12.6    
Credit Agreement | Arena Pharmaceuticals, Inc.        
Debt        
Maximum borrowing capacity 800.0      
Upfront payment $ 800.0      
Outstanding Balance     $ 1,050.0  
First unsecured revolving credit facility        
Debt        
Maximum borrowing capacity   1,000.0    
Second unsecured revolving credit facility        
Debt        
Maximum borrowing capacity   500.0    
Increase in borrowing capacity   $ 300.0    
Prior credit agreement        
Debt        
Interest expense       $ 2.6